Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
About this item
Full title
Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Author / Creator
Publisher
Boston: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2022-06, Vol.386 (25), p.2399-2411
Language
English
Formats
Publication information
Publisher
Boston: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Until recently, Ph-positive ALL was very aggressive and difficult to treat. Current frontline therapy, based on tyrosine kinase inhibitors, glucocorticoids, and blinatumomab, has increased survival, with high-level clearance of measurable tumor cells.
Alternative Titles
Full title
Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2679698271
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2679698271
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMra2113347
How to access this item
Log in as a Library member
